Curable renal hypertension: Renin, marker or cause? Question answered

American Journal of Hypertension

Volumn 27, Issue 8, 2014, Pages 1000-1003

  Vaughan, E Darracott ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KIDNEY RENIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; RENIN;

CURABLE RENAL HYPERTENSION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY FUNCTION; MEDICAL LITERATURE; NEPHRECTOMY; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLICATION; RENIN RELEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; ANIMAL; BLOOD; DISEASE MODEL; HISTORY; HYPERTENSION, RENAL; KIDNEY FUNCTION TEST; METABOLISM;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERTENSION, RENAL; HYPERTENSION, RENOVASCULAR; KIDNEY FUNCTION TESTS; RENIN;

EID: 84929132996     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu111     Document Type: Note

References (19)

1. Vaughan ED Jr., Sorenson EJ, Gillenwater JY. The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest. Urol. 1970; 8: 78-90.
2. Ayers CR, Harris RH Jr., Lefer LG. Control of renin release in experimental hypertension. Circ. Res. 1969; 24: (Suppl 5), 103-12.
3. Laragh JH. Curable renal hypertension-renin, marker or cause? JAMA 1971; 218: 733-34.
4. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 347-79.
5. Marks LS, Maxwell MH. Renal vein renin: value and limitations in the prediction of operative results. Urol. Clin. North Am. 1975; 2: 311-25.
6. Foster JH, Maxwell MH, Franklin SS, Bleifer KH, Trippel OH, Julian OC, DeCamp PT, Varady PT. Renovascular occlusive Disease. JAMA 1975; 231:1043-48.
7. Pals DT, Denning GS, Keenan RE. Historical development of Saralasin. Kidney Intl. Suppl. 1979; 9: S7-10.
8. Brunner HR, Kirshman JD, Sealey JE, Laragh JH. Hypertension of renal origin: Evidence for two different mechanisms. Science, 1971; 174: 1344-46.
9. Miller ED Jr., Samuels AI, Haber E, Barger AC. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 1972; 177: 1108-9.
10. Gavras H, Brunner HR, Vaughan ED Jr., Laragh JH. Angiotensinsodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 1973; 180: 1369-71.
11. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughan ED Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 1972; 52: 633-52.
12. Brunner HR, Gavras H, Laragh JH. Angiotensin II blockade in man by Sar1-ala8-angiotensin II for understanding and treatment of high blood pressure. The Lancet. 1973; II: 1045-48.
13. Tegtmeyer CJ, Latour EA, Vaughan ED Jr., Ayers CR, Carey RM, Wellons HA Jr. Clinical experience with Saralasin infusion in hypertensive patients. Invest. Radiol. 1977; 12: 496-504.
14. Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JIM, White RP, Sealey JE, Laragh JH. Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over Saralasin. Am. J. Med. 1976; 61: 790-96.
15. Marks LS, Maxwell MH, Varady PD, Lupu AN, Kaufman JJ. Renovascular hypertension: does renal vein renin ratio predict operative results? 1976; 115: 365-8.
16. Sealey JE, Buhler FR, Laragh JH, Vaughan ED Jr. The physiology of renin secretion in essential hypertension. Am. J. Med. 1973; 55: 391-01.
17. Gross F. The renin-angiotensin system in hypertension. Ann. Intern Med. 1971; 75: 777-87.
18. Stockigt JR, Collins RD, Noakes CA, Schambelan M, Biglieri EG. Renal-vein renin in various forms of renal hypertension. Lancet 1972; 1: 1194-7.
19. Vaughan ED Jr., Buhler FR, Laragh JH, Sealey JE, Baer L, Bard RH. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am. J. Med. 1973; 55:402-14.